| scholarly article | Q13442814 |
| P2093 | author name string | Augusto C Ochoa | |
| Paulo C Rodriguez | |||
| David G Quiceno | |||
| P2860 | cites work | Creatine and creatinine metabolism | Q28140735 |
| Molecular sites of regulation of expression of the rat cationic amino acid transporter gene | Q28564403 | ||
| Regulation of immune responses by L-arginine metabolism | Q29614284 | ||
| Molecular cloning of the rat TA1/LAT-1/CD98 light chain gene promoter | Q31905688 | ||
| Enzymes of arginine metabolism | Q34355739 | ||
| Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. | Q34593447 | ||
| Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox | Q34961072 | ||
| Linking cyclins to transcriptional control. | Q35012861 | ||
| Agmatine: at the crossroads of the arginine pathways | Q35694933 | ||
| Structure and function of arginases | Q35909707 | ||
| Cellular and physiological effects of arginine | Q35950387 | ||
| Arginine and immune function. | Q37847777 | ||
| Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27(Kip1) and p21(Cip1). | Q38319947 | ||
| Post-transcriptional regulation of the arginine transporter Cat-1 by amino acid availability | Q40923124 | ||
| Adaptive regulation of the cationic amino acid transporter-1 (Cat-1) in Fao cells | Q42442120 | ||
| Regulation of T cell receptor CD3zeta chain expression by L-arginine | Q43957769 | ||
| L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes | Q44521252 | ||
| Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). | Q44947169 | ||
| Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses | Q45020410 | ||
| Citrulline can preserve proliferation and prevent the loss of CD3 zeta chain under conditions of low arginine | Q45165505 | ||
| Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion | Q46440292 | ||
| GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. | Q46490849 | ||
| L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes | Q46515977 | ||
| L-Arginine | Q60156869 | ||
| Regulation of amino acid transport in chick embryo heart cells. I. Adaptive system of mediation for neutral amino acids | Q70404623 | ||
| Glutamine increases argininosuccinate synthetase mRNA levels in rat hepatocytes. The involvement of cell swelling | Q71047856 | ||
| L-Arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism | Q72322232 | ||
| Amino acid regulation of gene expression | Q74347727 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1568-1573 | |
| P577 | publication date | 2006-10-05 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | L-arginine availability regulates T-lymphocyte cell-cycle progression | |
| P478 | volume | 109 |
| Q64078967 | A Metabolism Toolbox for CAR T Therapy |
| Q38847251 | A clinical and biological perspective of human myeloid-derived suppressor cells in cancer |
| Q38891307 | A guide to immunometabolism for immunologists. |
| Q35640574 | A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. |
| Q36923029 | AMP-activated protein kinase regulates L-arginine mediated cellular responses |
| Q36277369 | Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia |
| Q37676894 | Activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma |
| Q35024746 | Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D. |
| Q93039755 | Advances and Challenges of CAR T Cells in Clinical Trials |
| Q34517267 | Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease |
| Q39899861 | All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function |
| Q92072042 | Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment |
| Q58582886 | Altered Cd8+ T lymphocyte Response Triggered by Arginase 1: Implication for Fatigue Intensification during Localized Radiation Therapy in Prostate Cancer Patients |
| Q36809767 | Altered macrophage differentiation and immune dysfunction in tumor development |
| Q35952614 | Altered tryptophan metabolism as a paradigm for good and bad aspects of immune privilege in chronic inflammatory diseases |
| Q36970801 | Amino acid auxotrophy as a system of immunological control nodes |
| Q35261125 | Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. |
| Q36674887 | Anti-leukemic mechanisms of pegylated arginase I in acute lymphoblastic T-cell leukemia |
| Q42082414 | Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response |
| Q49546319 | Antitumor T cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy |
| Q95270509 | Apolipoprotein A-I Mimetic Peptide L-4F Suppresses Granulocytic-Myeloid-Derived Suppressor Cells in Mouse Pancreatic Cancer |
| Q36917941 | Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation |
| Q33978763 | Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes |
| Q53694854 | Arginase-1 expression in myeloid cells regulates S. aureus planktonic but not biofilm infection. |
| Q82505222 | Arginase-dependent suppression by CpG-ODN plus IFA-induced splenic myeloid CD11b(+)Gr1(+) cells |
| Q50143099 | Arginase: A Multifaceted Enzyme Important in Health and Disease. |
| Q37395887 | Arginase: an emerging key player in the mammalian immune system |
| Q37700072 | Arginine Is a Critical Substrate for the Pathogenesis of Pseudomonas aeruginosa in Burn Wound Infections |
| Q39146030 | Arginine Metabolism in Myeloid Cells Shapes Innate and Adaptive Immunity |
| Q37118164 | Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives |
| Q39540843 | Arginine transport in human monocytic leukemia THP-1 cells during macrophage differentiation. |
| Q35988832 | B Cell-Intrinsic IDO1 Regulates Humoral Immunity to T Cell-Independent Antigens |
| Q40693170 | B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer. |
| Q57468064 | Bendamustine with total body irradiation limits murine graft-versus-host disease in part through effects on myeloid-derived suppressor cells |
| Q80838060 | Beneficial effects of L-arginine nitric oxide-producing pathway in rats treated with alloxan |
| Q84579625 | Between Scylla and Charibdis: eIF2α kinases as targets for cancer chemotherapy |
| Q92071397 | Beyond DNA Damage: Exploring the Immunomodulatory Effects of Cyclophosphamide in Multiple Myeloma |
| Q34541778 | Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13 |
| Q55363179 | Brazilian propolis ethanol extract and its component kaempferol induce myeloid-derived suppressor cells from macrophages of mice in vivo and in vitro. |
| Q60047537 | CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success |
| Q27003937 | COX-2 and PGE2-dependent immunomodulation in breast cancer |
| Q98291350 | Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment |
| Q91656807 | Cancer Metabolism Drives a Stromal Regenerative Response |
| Q37769017 | Cancer-associated myeloproliferation: old association, new therapeutic target |
| Q90812040 | Carnosic acid enhances the anti-lung cancer effect of cisplatin by inhibiting myeloid-derived suppressor cells |
| Q91871570 | Cationic Amino Acid Transporter-1-Mediated Arginine Uptake Is Essential for Chronic Lymphocytic Leukemia Cell Proliferation and Viability |
| Q92072332 | Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor Cells |
| Q38170150 | Cellular and molecular mechanisms in cancer immune escape: a comprehensive review |
| Q50973215 | Change of the metabolomic profile during short-term mononuclear cell storage. |
| Q37993530 | Characteristics of "Tip-DCs and MDSCs" and Their Potential Role in Leishmaniasis |
| Q33898612 | Chronic alcohol consumption enhances myeloid-derived suppressor cells in B16BL6 melanoma-bearing mice |
| Q37094951 | Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease |
| Q40398428 | Combination therapy with L-arginine and α-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice |
| Q34582640 | Combinations of immunotherapy and radiation in cancer therapy. |
| Q34093784 | Complex role for the immune system in initiation and progression of pancreatic cancer. |
| Q84595151 | Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis |
| Q27004733 | Control of the immune response by pro-angiogenic factors |
| Q37026641 | Creating immune privilege: active local suppression that benefits friends, but protects foes. |
| Q36958291 | Cross-species comparison of metabolite profiles in chemosensory epithelia: an indication of metabolite roles in chemosensory cells |
| Q27672035 | Crystal Structures of Complexes with Cobalt-Reconstituted Human Arginase I |
| Q40983895 | Cytotoxicity of tumor antigen specific human T cells is unimpaired by arginine depletion |
| Q40099659 | Deep Immune Profiling of an Arginine-Enriched Nutritional Intervention in Patients Undergoing Surgery |
| Q36388407 | Depletion of L-arginine induces autophagy as a cytoprotective response to endoplasmic reticulum stress in human T lymphocytes |
| Q37737817 | Designing T cells for cancer immunotherapy |
| Q90446931 | Dietary restriction of amino acids for Cancer therapy |
| Q37097116 | Differential impact of L-arginine deprivation on the activation and effector functions of T cells and macrophages |
| Q90744987 | Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration |
| Q46045308 | Effect of L-Arginine and L-NAME treatments on polymorphonuclear leukocytes and mononuclear cells influx during tumor growth |
| Q53464288 | Effect of Nitric Oxide Synthesis Blockade on the Morphology of Langerhans Islets in August and Wistar Rats with Acute Alloxan Diabetes. |
| Q37072738 | Effect of type of TAG fatty acids on lutein and zeaxanthin bioavailability |
| Q41896875 | Effects of cigarette smoke extract on primary activated T cells |
| Q39313554 | Energy metabolic pathways control the fate and function of myeloid immune cells |
| Q39249589 | Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the Fuel |
| Q26741623 | Epigenetics in myeloid derived suppressor cells: a sheathed sword towards cancer |
| Q39052920 | Exosomal Hsp70 mediates immunosuppressive activity of the myeloid-derived suppressor cells via phosphorylation of Stat3. |
| Q96230577 | Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) |
| Q36304952 | Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity |
| Q36390189 | Expression of arginase I and inducible nitric oxide synthase in the peripheral blood and lymph nodes of HIV‑positive patients |
| Q54403875 | Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease. |
| Q33335156 | Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration. |
| Q37699624 | Fasciola hepatica Immune Regulates CD11c+ Cells by Interacting with the Macrophage Gal/GalNAc Lectin. |
| Q36853435 | Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection |
| Q36303514 | Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus |
| Q33965172 | Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation |
| Q28390496 | Gr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infection |
| Q26863418 | Hampering immune suppressors: therapeutic targeting of myeloid-derived suppressor cells in cancer |
| Q91700929 | Heterogeneity of Ly6G+ Ly6C+ Myeloid-Derived Suppressor Cell Infiltrates during Staphylococcus aureus Biofilm Infection |
| Q37555500 | Hiding in Plain Sight: Interplay between Staphylococcal Biofilms and Host Immunity |
| Q38047057 | Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance. |
| Q26781286 | How Neutrophils Shape Adaptive Immune Responses |
| Q92324024 | Human Plasma-like Medium Improves T Lymphocyte Activation |
| Q90307119 | Human monocytic myeloid-derived suppressor cells impair B-cell phenotype and function in vitro |
| Q64090632 | Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma |
| Q34512092 | IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance |
| Q47656596 | Identification of a Novel Subset of Myeloid-Derived Suppressor Cells During Chronic Staphylococcal Infection That Resembles Immature Eosinophils |
| Q53443562 | Identifying Biomarkers of Wharton's Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect. |
| Q91272360 | Immune control by amino acid catabolism during tumorigenesis and therapy |
| Q37386324 | Immune regulation by non-lymphoid cells in transplantation. |
| Q27027064 | Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences |
| Q35120242 | Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway |
| Q58802811 | Immunometabolism in cancer at a glance |
| Q38613635 | Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration. |
| Q50085942 | Immunometabolism, pregnancy, and nutrition. |
| Q91451790 | Immunophenotypes associated with bipolar disorder and lithium treatment |
| Q54918600 | Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer. |
| Q36821077 | Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course |
| Q90172862 | Immunosurveillance of cancer cell stress |
| Q38374836 | Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study. |
| Q52332683 | Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy. |
| Q35005894 | Impaired T cell function in argininosuccinate synthetase deficiency |
| Q91651633 | Increased Expression of Myeloid-Derived Suppressor Cells in Patients with HBV-Related Hepatocellular Carcinoma |
| Q37483023 | Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients |
| Q36330142 | Increased level of arginase activity correlates with disease severity in HIV-seropositive patients |
| Q34576982 | Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia |
| Q34308495 | Indoleamine 2,3 dioxygenase and metabolic control of immune responses |
| Q50703292 | Induced arginine transport via cationic amino acid transporter-1 is necessary for human T-cell proliferation. |
| Q38202992 | Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases |
| Q92423403 | Induction of tryptophan 2,3-dioxygenase expression in human monocytic leukemia/lymphoma cell lines THP-1 and U937 |
| Q42161162 | Inhibition of endogenous activated protein C attenuates experimental autoimmune encephalomyelitis by inducing myeloid-derived suppressor cells |
| Q53796096 | Innate Lymphoid Cells in Tumor Immunity. |
| Q92560950 | Innate lymphoid cells: A potential link between microbiota and immune responses against cancer |
| Q38492085 | Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases |
| Q39275844 | Interferon-gamma-induced nitric oxide inhibits the proliferation of murine renal cell carcinoma cells |
| Q37359052 | L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity |
| Q57845354 | L-Arginine modulates neonatal lymphocyte proliferation through an interleukin-2 independent pathway |
| Q36035570 | L-Arginine supplementation inhibits the growth of breast cancer by enhancing innate and adaptive immune responses mediated by suppression of MDSCs in vivo |
| Q41767433 | L-arginine and Alzheimer's disease. |
| Q34167773 | L-arginine deprivation impairs Leishmania major-specific T-cell responses |
| Q37015574 | L-arginine metabolism and its impact on host immunity against Leishmania infection |
| Q28475723 | Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis |
| Q39027509 | Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model |
| Q47564561 | M(IL-4) Tissue Macrophages Support Efficient Interferon-Gamma Production in Antigen-Specific CD8+ T Cells with Reduced Proliferative Capacity |
| Q34168497 | Macrophage Expression of Hypoxia-Inducible Factor-1α Suppresses T-Cell Function and Promotes Tumor Progression |
| Q30578330 | Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy |
| Q37010267 | Mechanism of T cell tolerance induction by murine hepatic Kupffer cells |
| Q50089395 | Mechanisms regulating T-cell infiltration and activity in solid tumors |
| Q26741252 | Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune Regulation |
| Q64088355 | Metabolic Control of Dendritic Cell Functions: Digesting Information |
| Q39265746 | Metabolic Cooperation and Competition in the Tumor Microenvironment: Implications for Therapy. |
| Q39452100 | Metabolic Interactions in the Tumor Microenvironment |
| Q35690250 | Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. |
| Q46291182 | Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond |
| Q38047050 | Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives |
| Q36718698 | Microenvironment generated during EGFR targeted killing of pancreatic tumor cells by ATC inhibits myeloid-derived suppressor cells through COX2 and PGE2 dependent pathway |
| Q48306002 | Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences. |
| Q35737437 | Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease |
| Q35697896 | Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune Microenvironment |
| Q46246507 | Modulation of Immune Signaling and Metabolism Highlights Host and Fungal Transcriptional Responses in Mouse Models of Invasive Pulmonary Aspergillosis |
| Q37808561 | Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function |
| Q39370979 | Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health. |
| Q90043574 | Monocytes and Macrophages in Cancer: Unsuspected Roles |
| Q39441390 | Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap. |
| Q35799153 | Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells |
| Q94017312 | Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery |
| Q92067766 | Myeloid derived suppressor cells are reduced and T regulatory cells stabilised in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega 3 |
| Q36338349 | Myeloid derived suppressor cells in human diseases |
| Q38160782 | Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly |
| Q36845851 | Myeloid derived suppressor cells: Targets for therapy |
| Q55295587 | Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors. |
| Q89976160 | Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer |
| Q96303603 | Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation |
| Q47651773 | Myeloid-Derived Suppressor Cells in the Tumor Microenvironment: Current Knowledge and Future Perspectives |
| Q38047053 | Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development. |
| Q37066106 | Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape |
| Q37697695 | Myeloid-derived suppressor cells and myeloid regulatory cells in cancer and autoimmune disorders |
| Q38864758 | Myeloid-derived suppressor cells as effectors of immune suppression in cancer. |
| Q28131637 | Myeloid-derived suppressor cells as regulators of the immune system |
| Q37732211 | Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection |
| Q38578686 | Myeloid-derived suppressor cells in B cell malignancies. |
| Q27014189 | Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications |
| Q38161536 | Myeloid-derived suppressor cells in glioma |
| Q58735079 | Myeloid-derived suppressor cells in non-neoplastic inflamed organs |
| Q35852813 | Myeloid-derived suppressor cells participate in preventing graft rejection |
| Q39331381 | Myeloid-derived suppressor cells-a new therapeutic target to overcome resistance to cancer immunotherapy. |
| Q89471834 | Myeloid-derived suppressor cells-new and exciting players in lung cancer |
| Q38821941 | Myeloid-derived suppressor cells: The green light for myeloma immune escape. |
| Q37393000 | Myeloid-derived suppressor cells: a novel therapeutic target |
| Q38028470 | Myeloid-derived suppressor cells: mechanisms of action and recent advances in their role in transplant tolerance. |
| Q36996588 | Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity |
| Q37019136 | Myeloid-derived suppressor cells: natural regulators for transplant tolerance |
| Q90751684 | NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis |
| Q58595932 | NRF2 Is One of the Players Involved in Bone Marrow Mediated Drug Resistance in Multiple Myeloma |
| Q41686071 | Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity. |
| Q39279665 | Neuroblastoma arginine addiction subverts the anticancer immune response. |
| Q38936555 | Neutrophils in cancer |
| Q34667638 | Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients |
| Q37786691 | Neutrophils: Cinderella of innate immune system |
| Q38057995 | New functions of protein kinase Gcn2 in yeast and mammals. |
| Q37689449 | Nutrient and Metabolic Sensing in T Cell Responses |
| Q92082162 | Nutritional Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of Neuroinflammation and Neurological Disease |
| Q90212537 | Obesity and CD8 T cell metabolism: Implications for anti-tumor immunity and cancer immunotherapy outcomes |
| Q64110944 | Orchestration of Adaptive T Cell Responses by Neutrophil Granule Contents |
| Q36891566 | Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome |
| Q31139529 | Overexpression of arginine transporter CAT-1 is associated with accumulation of L-arginine and cell growth in human colorectal cancer tissue |
| Q41708842 | PEGylated arginine deiminase can modulate tumor immune microenvironment by affecting immune checkpoint expression, decreasing regulatory T cell accumulation and inducing tumor T cell infiltration |
| Q39405279 | Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner |
| Q38579710 | Parallel Expression of Enzyme Inhibitors of CD8T Cell Activity in Tumor Microenvironments and Secretory Endometrium |
| Q37080079 | Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion. |
| Q39033973 | Parenteral or Enteral Arginine Supplementation Safety and Efficacy |
| Q89746192 | Pathway mapping of leukocyte transcriptome in influenza patients reveals distinct pathogenic mechanisms associated with progression to severe infection |
| Q26777205 | Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate |
| Q33944287 | Pegylated arginase I: a potential therapeutic approach in T-ALL |
| Q38134686 | Pharmaconutrition review: physiological mechanisms |
| Q37761657 | Polyamine metabolism in Leishmania: from arginine to trypanothione |
| Q35116475 | Possible role of arginase-1 in concomitant tumor immunity |
| Q38718929 | Prevention and treatment of cancers by immune modulating nutrients. |
| Q39229993 | Proliferating Helper T Cells Require Rictor/mTORC2 Complex to Integrate Signals from Limiting Environmental Amino Acids |
| Q92427972 | Rapid and Safe Isolation of Human Peripheral Blood B and T Lymphocytes through Spiral Microfluidic Channels |
| Q38728953 | Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma |
| Q39823199 | Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis. |
| Q38633026 | Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase Expression |
| Q92932387 | Regulation of T cell antitumor immune response by tumor induced metabolic stress |
| Q37982182 | Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells |
| Q28388235 | Regulatory dendritic cells: there is more than just immune activation |
| Q35799094 | Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. |
| Q89957128 | Resistance to Checkpoint Inhibition in Cancer Immunotherapy |
| Q37606102 | Role of immune cells in pancreatic cancer from bench to clinical application: An updated review |
| Q60046853 | Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis |
| Q66226605 | Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma. |
| Q40438223 | Stress Kinase GCN2 Controls the Proliferative Fitness and Trafficking of Cytotoxic T Cells Independent of Environmental Amino Acid Sensing |
| Q34944820 | Stromal-dependent tumor promotion by MIF family members |
| Q48012994 | Supplement of L-Arg improves protective immunity during early-stage Plasmodium yoelii 17XL infection |
| Q41652875 | Supplemental carvacrol can reduce the severity of inflammation by influencing the production of mediators of inflammation |
| Q52653346 | Supplemental dietary L-arginine attenuates intestinal mucosal disruption during a coccidial vaccine challenge in broiler chickens. |
| Q61798869 | Suppression of Myeloid Cell Arginase Activity leads to Therapeutic Response in a NSCLC Mouse Model by Activating Anti-Tumor Immunity |
| Q90162757 | T Cell Activation Depends on Extracellular Alanine |
| Q40428965 | T Cells Encountering Myeloid Cells Programmed for Amino Acid-dependent Immunosuppression Use Rictor/mTORC2 Protein for Proliferative Checkpoint Decisions. |
| Q37334065 | T cell regulatory plasmacytoid dendritic cells expressing indoleamine 2,3 dioxygenase |
| Q37109540 | T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy |
| Q37002795 | T-cell death and cancer immune tolerance |
| Q36809157 | TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation |
| Q47765346 | Targeting Myeloid-Derived Suppressor Cells in Cancer |
| Q55265921 | Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression. |
| Q92297313 | Targeting metabolism to regulate immune responses in autoimmunity and cancer |
| Q90729582 | The Antitumor and Immunomodulatory Effect of Yanghe Decoction in Breast Cancer Is Related to the Modulation of the JAK/STAT Signaling Pathway |
| Q28077757 | The Crosstalk between Myeloid Derived Suppressor Cells and Immune Cells: To Establish Immune Tolerance in Transplantation |
| Q90056672 | The Engagement Between MDSCs and Metastases: Partners in Crime |
| Q28391079 | The Intercellular Metabolic Interplay between Tumor and Immune Cells |
| Q90043597 | The Metabolic Remodelling in Lung Cancer and Its Putative Consequence in Therapy Response |
| Q91708004 | The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game |
| Q59804789 | The Yin and Yang of Myeloid Derived Suppressor Cells |
| Q91937333 | The clock is ticking: the impact of ageing on T cell metabolism |
| Q34557531 | The consequence of immune suppressive cells in the use of therapeutic cancer vaccines and their importance in immune monitoring |
| Q33592056 | The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data |
| Q98177248 | The immunology of renal cell carcinoma |
| Q26851643 | The impact of the myeloid response to radiation therapy |
| Q92314188 | The influence of microenvironment on tumor immunotherapy |
| Q34090829 | The protective role of myeloid-derived suppressor cells in concanavalin A-induced hepatic injury |
| Q36063617 | The role of leishmania proteophosphoglycans in sand fly transmission and infection of the Mammalian host |
| Q28654584 | The role of myeloid-derived suppressor cells in immune ontogeny |
| Q26752629 | The role of neutrophils in immune dysfunction during severe inflammation |
| Q93094713 | The tumor microenvironment in renal cell cancer |
| Q36473355 | Therapeutic interventions to disrupt the protein synthetic machinery in melanoma |
| Q104111165 | Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death |
| Q91361821 | Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background |
| Q26751022 | Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms |
| Q35361431 | Tumor microenvironment: a new treatment target for cancer |
| Q39123136 | Tumor regulation of the tissue environment in the liver |
| Q49168232 | Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer |
| Q39148281 | Tumor-associated macrophages: implications in cancer immunotherapy |
| Q33763653 | Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. |
| Q59799202 | Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression |
| Q38193589 | Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells. |
| Q89653483 | Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme |
| Q39224315 | Unleashing the immune response against childhood solid cancers |
| Q57818269 | Update on Neutrophil Function in Severe Inflammation |
| Q26991991 | Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes |
| Q35027087 | l-Arginine Deprivation Regulates Cyclin D3 mRNA Stability in Human T Cells by Controlling HuR Expression |
| Q34979666 | l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells |
| Q47107446 | l-Citrulline Metabolism in Mice Augments CD4+ T Cell Proliferation and Cytokine Production In Vitro, and Accumulation in the Mycobacteria-Infected Lung |
| Q92588804 | mTOR and Aging: An Old Fashioned Dress |
| Q26744447 | mTOR inhibitors effects on regulatory T cells and on dendritic cells |
| Q35207111 | Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8 |
| Q35970488 | Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells |
Search more.